2-((2,4,8,10-TETRAKIS(1,1-DIMETHYLETHYL)DIBENZO(D,F)(1,3,2)-DIOXAPHOSPHEPIN-6-YL)OXY)-N,N-BIS(2-((2,4,8,10-TETRAKIS(1,1-DIMETHYLETHYL)DIBENZO(D,F)(1,3,2)-DIOXAPHOSPHEPHEPIN-6-YL)OXY)ETHYL)ETHANAMINE
General Information
| Mainterm | 2-((2,4,8,10-TETRAKIS(1,1-DIMETHYLETHYL)DIBENZO(D,F)(1,3,2)-DIOXAPHOSPHEPIN-6-YL)OXY)-N,N-BIS(2-((2,4,8,10-TETRAKIS(1,1-DIMETHYLETHYL)DIBENZO(D,F)(1,3,2)-DIOXAPHOSPHEPHEPIN-6-YL)OXY)ETHYL)ETHANAMINE |
| CAS Reg.No.(or other ID) | 80410-33-9 |
| Regnum |
178.2010 |
From www.fda.gov
Computed Descriptors
Download SDF| 2D Structure | |
| CID | 174215 |
| IUPAC Name | 2-(2,4,8,10-tetratert-butylbenzo[d][1,3,2]benzodioxaphosphepin-6-yl)oxy-N,N-bis[2-(2,4,8,10-tetratert-butylbenzo[d][1,3,2]benzodioxaphosphepin-6-yl)oxyethyl]ethanamine |
| InChI | InChI=1S/C90H132NO9P3/c1-79(2,3)55-43-61-62-44-56(80(4,5)6)50-68(86(22,23)24)74(62)96-101(95-73(61)67(49-55)85(19,20)21)92-40-37-91(38-41-93-102-97-75-63(45-57(81(7,8)9)51-69(75)87(25,26)27)64-46-58(82(10,11)12)52-70(76(64)98-102)88(28,29)30)39-42-94-103-99-77-65(47-59(83(13,14)15)53-71(77)89(31,32)33)66-48-60(84(16,17)18)54-72(78(66)100-103)90(34,35)36/h43-54H,37-42H2,1-36H3 |
| InChI Key | YAGPRJYCDKGWJR-UHFFFAOYSA-N |
| Canonical SMILES | CC(C)(C)C1=CC(=C2C(=C1)C3=CC(=CC(=C3OP(O2)OCCN(CCOP4OC5=C(C=C(C=C5C6=CC(=CC(=C6O4)C(C)(C)C)C(C)(C)C)C(C)(C)C)C(C)(C)C)CCOP7OC8=C(C=C(C=C8C9=CC(=CC(=C9O7)C(C)(C)C)C(C)(C)C)C(C)(C)C)C(C)(C)C)C(C)(C)C)C(C)(C)C)C(C)(C)C |
| Molecular Formula | C90H132NO9P3 |
| Wikipedia | tris(2-((2,4,8,10-tetra-tert- butyldibenzo(D,f)(1,3,2)dioxaphosphepin-6-yl)oxy)ethyl)amine |
From Pubchem
Computed Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 1464.965 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 24 |
| Complexity | 2250.0 |
| CACTVS Substructure Key Fingerprint | A A A D c f B + P A M A A A A A A A A A A A A A A A A A A A A A A A A w Y M G D B I k A A A A B / g A A H g A A A C A A D g T h m A Y y B s M A A R C I Q q B S A I A C A A A k I A A A i A E M C M g K J j K A F R K A M Q A k w B G Y i Y f L y P C P o A A C A A A I A A B A A A Q A A B A A A A A A A A A A A A = = |
| Topological Polar Surface Area | 110.0 |
| Monoisotopic Mass | 1463.911 |
| Exact Mass | 1463.911 |
| XLogP3 | None |
| XLogP3-AA | 29.9 |
| Compound Is Canonicalized | True |
| Formal Charge | 0 |
| Heavy Atom Count | 103 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.8963 |
| Human Intestinal Absorption | HIA+ | 0.9632 |
| Caco-2 Permeability | Caco2+ | 0.5162 |
| P-glycoprotein Substrate | Substrate | 0.7623 |
| P-glycoprotein Inhibitor | Inhibitor | 0.9259 |
| Inhibitor | 0.5153 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5738 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.4567 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.7778 |
| CYP450 2D6 Substrate | Non-substrate | 0.7034 |
| CYP450 3A4 Substrate | Substrate | 0.7553 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7107 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7987 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7439 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7141 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.8627 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6480 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Strong inhibitor | 0.8503 |
| Inhibitor | 0.6637 | |
| AMES Toxicity | Non AMES toxic | 0.7234 |
| Carcinogens | Non-carcinogens | 0.6922 |
| Fish Toxicity | High FHMT | 0.8159 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9468 |
| Honey Bee Toxicity | High HBT | 0.7644 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.5231 |
| Carcinogenicity (Three-class) | Non-required | 0.5453 |
From admetSAR
ADMET Predicted Profile --- Regression
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -3.9993 | LogS |
| Caco-2 Permeability | 0.7499 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 2.5989 | LD50, mol/kg |
| Fish Toxicity | 0.9382 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.5530 | pIGC50, ug/L |
From admetSAR